𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PND3 A RAPID REVIEW OF ECONOMIC EVALAUTIONS OF DONEPEZIL, RIVASTIGMINE, GALANTAMINE AND MEMANTINE FOR ALZHEIMER'S DISEASE (AD)

✍ Scribed by Feng, J; Huang, R; Pwee, K

Book ID
123016468
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
65 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Review of donepezil, rivastigmine, galan
Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population
✍ V. P. Prasher πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## Abstract The management of dementia in Alzheimer's disease has dramatically changed since the development of anti‐dementia drugs. However, there is limited information available regarding the bio‐medical aspects of the differing drugs; particularly relating to adults with intellectual disability

A systematic review of the clinical effe
A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease
✍ A. Takeda; E. Loveman; A. Clegg; J. Kirby; J. Picot; E. Payne; C. Green πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## Abstract ## Background The use of cholinesterase inhibiors for Alzheimer's disease (AD) is currently being appraised by the National Institute for Clintical Evidence (NICE). This article provides the latest evidence that NICE will be using as part of this appraisal process. ## Objective To pr